5.0
20. Mai 2026
Aktueller Mitarbeiter, mehr als 1 Jahr
Uppal
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
The company in terms of its services/products and global reach is amazing. Excelra possesses premium datasets for Drug Discovery which include GOSTAR and GOBIOM.
Kontras
There are no cons as I have seen in this company